The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

and fulfilling its statutory mandate to maintain an “up-to-date” drug shortage list, among other things. This order relates to certain FDA-approved Mounjaro and Zepbound products. The Mounjaro ...

Ultragenyx Pharmaceutical RARE announced that the European Commission (EC) has expanded the eligible patient population for ...

Gone are the days when Americans would criticize eggs for bad cholesterol. The FDA has put its stamp of approval for kids to ...

In its second attempt, Takeda has secured FDA approval for Eohilia ... oral suspension formulation of the well-established steroid drug budesonide, for people 11 years and older with EoE after ...

Bryan Johnson, the founder of Braintree and subject of a new Netflix doc, is on a quest for remarkable longevity.

With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

Finding an effective supplement that aligns with your fitness goals can be daunting in the world of health and wellness.

Viking Therapeutics (VKTX) is identified by Oppenheimer among five potential biotech M&A candidates ahead of J.P. Morgan Healthcare Conference. Read more here.